Eyeworld

EW MEETING REPORTER 168 March 2015 miss it with staining if you put in too much," he said. "Just dab the conjunctiva to get a thin layer that will really show the lesions." To manage patients with ABMD or Salzmann's nodules, Drs. Lee and Kim recommend performing a superficial keratectomy, waiting 6–8 weeks for the cornea to heal and the topography to stabilize, and then performing cataract surgery. When treating corneal en- dothelial disease, both DSEK and DMEK are viable options, but DMEK induces less of a hyperopic shift, Dr. Lee said. Because the procedures are so new, it is difficult to compare outcomes of visual acuity and endo- thelial cell loss between them, but surgeons may be able to do that in the next several years. Editors' note: Dr. Holland has financial interests with Alcon, Bausch + Lomb, Kala Pharmaceuticals, Rapid Pathogen Screening, TearLab, and TearScience. Dr. Kim has financial interests with Al- con, Bausch + Lomb, Kala Pharmaceu- ticals, NovaBay Pharmaceuticals, and TearScience. Dr. Lee has financial inter- ests with Allergan and Bausch + Lomb. Dr. Yeu has financial interests with Abbott Medical Optics, Alcon, Aller- gan, Bausch + Lomb, Rapid Pathogen Screening, TearLab, and TearScience. Pearls for routine, challenging, and complicated cataract surgeries In a video case-based symposium, faculty members Eric Donnenfeld, MD, New York, Robert J. Cionni, MD, Salt Lake City, Stephen S. Lane, MD, Stillwater, Minn., Kerry Solomon, MD, Mount Pleasant, S.C., and Robert Weinstock, MD, Largo, Fla., shared pearls they have learned from routine, challenging, and complicated cataract surgeries. Dr. Donnenfeld presented 2 videos of femtosecond laser-assisted surgery, which he considers to be the future of cataract surgery. "I love this technology, I think it's got great potential," he said. "The economics are the difficult part of femtosecond cataract surgery today, but the economics will be worked out—technology always wins. If we've got a better way of do- ing things, we're going to do that." Although many physicians are hesitant to adopt it, Dr. Donnenfeld thinks that will change in the future. "Eventually, everyone here will be doing this, and you have to find the time that's right for you," he said. "When you feel comfortable doing it, you should gravitate to it." Dr. Donnenfeld said that he currently performs about 75% of his cataract surgeries with the femto- second laser, eliminating the need for phacoemulsification in many of those cases. "I predict that femto- second laser surgery will become an aspirational procedure where fluidics will drive cataract surgery in the very near future, and phacoemulsifi- cation as we know it today will die," he said. "Going forward, for people who are having femto, it will be a pure fluidics procedure." Dr. Donnenfeld's presentation sparked a discussion about benefits of femtosecond cataract surgery among the other panelists. "It completely changes how challenging it is to get that cataract out, and I feel that's the very best benefit of the laser," Dr. Weinstock said. "The softening of the lens, reducing the thermal damage from Reporting from ASCRS•ASOA SideXSide 2015, Aventura, Fla., February 12–15 View videos from Saturday at SideXSide 2015: EWrePlay.org Elizabeth Yeu, MD, Norfolk, Va., explains that ocular surface disease should be recognized and treated before biometry is obtained. View videos from Saturday at SideXSide 2015: EWrePlay.org Thomas Samuelson, MD, Minneapolis, describes the role of MIGS for patients with more advanced disease.

• Cover